Tolazamide
Tolazamide is a first-generation sulfonylurea that stimulates insulin secretion from pancreatic beta cells by binding to and blocking ATP-sensitive potassium channels (KATP), causing membrane depolarization, calcium influx, and insulin granule exocytosis. It is used as an oral antidiabetic agent for type 2 diabetes in patients where diet and exercise are insufficient, and has also been used in cardiovascular risk stratification studies. Its mechanism depends on functional beta cells and is ineffective in type 1 diabetes.
Moleküler Ağırlık
311,4000 g/mol
LogP
1,50
TPSA
86,90 Ų
Lipinski RO5
Geçer
Terapötik Alanlar
Pharmacokinetics (PK)
Pharmacodynamics (PD)
2D Yapı
Cite this structure
Embed this structure
SMILES
Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1
InChI
InChI=1S/C14H21N3O3S/c1-12-6-8-13(9-7-12)21(19,20)16-14(18)15-17-10-4-2-3-5-11-17/h6-9H,2-5,10-11H2,1H3,(H2,15,16,18)
Molecular Formula
C14H21N3O3S
HBD / HBA
2 / 4
Döndürülebilir Bağlar
3
Ağır Atomlar
21
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
Tolazamide is a first-generation sulfonylurea that stimulates insulin secretion from pancreatic beta cells by binding to and blocking ATP-sensitive potassium channels (KATP), causing membrane depolarization, calcium influx, and insulin granule exocytosis. It is used as an oral antidiabetic agent for type 2 diabetes in patients where diet and exercise are insufficient, and has also been used in cardiovascular risk stratification studies. Its mechanism depends on functional beta cells and is ineffective in type 1 diabetes.
Yes, Tolazamide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL817. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 5503. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="tolazamide"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/tolazamide/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/tolazamide/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/tolazamide/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="tolazamide"></drugfyi-drug>